Hizentra
Payments companies reported to CMS as associated with Hizentra. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Hizentra, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Hizentra
These are the largest totals companies reported as associated with Hizentra. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Suraj Muley | Phoenix, AZ | Neurology (Psychiatry & Neurology) | $158,176.26 |
| Christopher Scheiner | Dayton, OH | Neurology (Psychiatry & Neurology) | $142,535.77 |
| Todd Hrabak | Glendale, AZ | Allergy | $112,976.21 |
| Michael Palumbo | Pittsburgh, PA | Allergy | $104,739.45 |
| Raffi Tachdjian | Santa Monica, CA | Allergy & Immunology | $95,325.01 |
| Jeffery Allen | Minneapolis, MN | Neurology (Psychiatry & Neurology) | $87,438.88 |
| Mark Ballow | Tampa, FL | Pediatric Allergy/Immunology | $84,581.75 |
| Christina Price | New Haven, CT | Allergy & Immunology | $54,855.81 |
| Tuan Vu | Tampa, FL | Neurology (Psychiatry & Neurology) | $53,556.64 |
| William Blouin | Miami, FL | $48,557.75 |
Prescribed Hizentra?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.